(Total Views: 463)
Posted On: 03/23/2020 7:31:35 PM
Post# of 154227
All you armchair quarterbacks emailing NP should double-check your own writing. It’s hear, hear not here, here. And it’s fan fare not fan fair.
These articles are meaningless. Institutions aren’t *not* buying bc of a paid article. They’re not buying because we’re on the OTC and trading at a buck. The alternative here is for NP to just stay completely silent until results push us over $2 and/or we have the revenue to uplist.
I don’t care about typos (as annoying as they are). I care about BLA, BTD, and how our CV patients are doing.
These articles are meaningless. Institutions aren’t *not* buying bc of a paid article. They’re not buying because we’re on the OTC and trading at a buck. The alternative here is for NP to just stay completely silent until results push us over $2 and/or we have the revenue to uplist.
I don’t care about typos (as annoying as they are). I care about BLA, BTD, and how our CV patients are doing.
(10)
(0)
